Sila Realty Trust (SILA) Shareholders Approve Blue Owl Capital (OWL) Acquisition in Healthcare REIT Deal

The Quick Take

• Sila Realty Trust (SILA) shareholders have voted to approve the acquisition by Blue Owl Capital (OWL), removing a key deal uncertainty and clearing the path to close.
• Blue Owl Capital is a leading alternative asset manager acquiring SILA to expand its real asset and healthcare property exposure.
• The shareholder vote approval narrows the merger arbitrage spread and advances the timeline to final close pending any remaining regulatory approvals.

Sila Realty Trust (SILA) shareholders have voted to approve the acquisition by Blue Owl Capital (OWL), representing a critical deal milestone that removes shareholder uncertainty and advances the transaction toward final close. Sila Realty Trust is a non-traded REIT focused on healthcare real estate, including medical office buildings, surgical facilities, and other specialty healthcare properties. Blue Owl Capital, an alternative asset management firm, is acquiring SILA as part of a strategic expansion into real asset holdings that provide fee-generating and portfolio diversification advantages for its institutional client base.

The shareholder approval vote is a significant milestone in the deal process. Non-traded REITs like SILA require shareholder votes for liquidation or acquisition transactions, and the successful approval demonstrates that the consideration offered by Blue Owl reflected fair value relative to SILA's portfolio net asset value as independently assessed. For investors participating in merger arbitrage strategies on SILA, the shareholder vote approval narrows the spread between the current trading price and the deal consideration value, with the remaining uncertainty concentrated in regulatory review timelines and deal close mechanics rather than shareholder opposition risk.

The Blue Owl-SILA deal adds to the growing trend of alternative asset managers expanding into real asset strategies to diversify revenue streams beyond traditional private equity and credit. Healthcare real estate has been an attractive acquisition target due to demographic demand drivers from aging populations and the sector's relative insulation from commercial real estate headwinds that have affected office and retail properties. For the broader healthcare REIT sector, the Blue Owl acquisition establishes a recent comparable transaction data point that can inform cap rate and valuation assessments for similar portfolios of medical office, surgical center, and specialty healthcare properties across the US.

Synthesized from 1 source.